We showed that supplementation with selenite in the tissue culture media synergistically enhanced the toxicity of SEPHS2 KO in cancer cells, suggesting that with this type of approach, pharmacological inhibition of the detoxifying enzyme may be combined with dietary supplementation with metabolic precursors to the toxic metabolite. The gene discussed is SEPHS2; the disease is cancer.